Results 21 to 30 of about 819,215 (267)
Survival of 48866 cancer patients: results from Nantong area, China
Frontiers in Oncology, 2023 ObjectiveThis study aimed to provide a realistic observation of survival by major site for 48,866 cancer patients treated at a tertiary cancer hospital in a rural area of China.MethodsPatients with cancer registered between 2007 and 2017 in the Nantong ...
Gao-Ren Wang +11 more
doaj +1 more source
Nutrition and Chronic Liver Disease
Clinical Drug Investigation, 2022 Malnutrition is common in chronic liver diseases and worsens the patient's prognosis. Many liver disorders are associated with nutritional deficiencies. Some of the main factors that can lead to malnutrition in patients with chronic liver disease include decreased lipid absorption and reduced albumin production.
openaire +2 more sources
Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases [PDF]
Zhongguo quanke yixue, 2023 The liver is the largest metabolic organ in the human body, and impaired liver function can lead to a variety of acute and chronic liver diseases, which can affect the quality of life in mild cases or be life-threatening in severe cases. Therefore, it is
YUAN Xiwei, NAN Yuemin
doaj +1 more source
BMC Microbiology, 2023 Objective Staphylococcus aureus (S. aureus), especially Methicillin resistant S. aureus (MRSA), has been disseminated across communities and hospitals, associated with severe infections and organ failure.
Jiarong Zhang +3 more
doaj +1 more source
Angiogenesis in chronic liver disease
Annals of Hepatology, 2007 Chronic liver disease is characterized by inflammation and fibrosis. As a consequence angiogenesis leading to new vasculature may have prognostic value in disease progression. Interfering with angiogenesis may be a potential target to avoid progression of liver disease. Hence we planned to evaluate the CD34 and vascular endothelial growth factor (VEGF),
Anjali D. Amarapurkar +3 more
openaire +3 more sources
Osteodystrophy in chronic liver diseases [PDF]
Internal and Emergency Medicine, 2012 Osteoporosis and osteomalacia are, to date, among the most common metabolic diseases in the world. Lately, an association between metabolic bone diseases and chronic liver disease has been increasingly reported, inducing many authors to create a new nosographic entity known as 'hepatic osteodystrophy.' The importance of such a condition is further ...
MANSUETO, Pasquale +4 more
openaire +3 more sources
Thrombocytopenia in chronic liver disease [PDF]
Liver International, 2016 AbstractThrombocytopenia is a common haematological disorder in patients with chronic liver disease. It is multifactorial and severity of liver disease is the most influential factor. As a result of the increased risk of bleeding, thrombocytopenia may impact upon medical procedures, such as surgery or liver biopsy.
openaire +2 more sources
Molecular Oncology, 2019 The cross‐talk between hepatic stellate cells (HSCs) and hepatic carcinoma cells contributes to hepatocellular carcinoma (HCC) progression, but the underlying mechanism is largely unknown.
Jie Li +17 more
doaj +1 more source
RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31
Cell Death Discovery, 2022 RNF31 (HOIP), RBCK1 (HOIL-1L), and SHARPIN are subunits of the linear ubiquitin chain assembly complex. Their function and specific molecular mechanisms in hepatocellular carcinoma (HCC) have not been reported previously.
Xijun Chen +5 more
doaj +1 more source
Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
Viruses, 2022 The currently available antiviral treatments (Peg-Interferon-α and Nucleos(t)ide Analogues, NA) for chronic hepatitis B (CHB) achieve a functional cure (serum HBsAg and HDV-DNA clearance) of HBV infection in a limited number of patients.
Piero Colombatto +3 more
doaj +1 more source